Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
21
NXGL Quote, Financials, Valuation and Earnings
Last price:
$1.60
Seasonality move
:
-0.29%
Day range:
$1.56 - $1.60
52-week range:
$1.45 - $4.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.04x
P/B ratio:
2.50x
Volume:
24.9K
Avg. volume:
87.5K
1-year change:
-66.46%
Market cap:
$12.9M
Revenue:
$8.7M
EPS (TTM):
-$0.38
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NXGL
NexGel, Inc.
|
$3.2M | -$0.08 | 6.54% | -22.68% | $6.00 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
COO
The Cooper Cos., Inc.
|
$1.1B | $1.11 | 6.12% | 98.42% | $90.50 |
|
KIDS
OrthoPediatrics Corp.
|
$62M | -$0.26 | 12.55% | -54.72% | $24.13 |
|
LUCY
Innovative Eyewear, Inc.
|
$1M | -$0.49 | 73.74% | -50.4% | $3.00 |
|
STAA
STAAR Surgical Co.
|
$89.4M | $0.28 | 54.33% | 39.51% | $26.56 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NXGL
NexGel, Inc.
|
$1.59 | $6.00 | $12.9M | -- | $0.00 | 0% | 1.04x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.8150 | $12.3077 | $209.3M | -- | $0.00 | 0% | 190.87x |
|
COO
The Cooper Cos., Inc.
|
$82.57 | $90.50 | $16.2B | 44.06x | $0.01 | 0% | 4.04x |
|
KIDS
OrthoPediatrics Corp.
|
$17.41 | $24.13 | $436.6M | -- | $0.00 | 0% | 1.79x |
|
LUCY
Innovative Eyewear, Inc.
|
$1.36 | $3.00 | $7.3M | -- | $0.00 | 0% | 1.85x |
|
STAA
STAAR Surgical Co.
|
$23.63 | $26.56 | $1.2B | 49.73x | $0.00 | 0% | 5.09x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NXGL
NexGel, Inc.
|
38.1% | -0.508 | 15.76% | 0.82x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
COO
The Cooper Cos., Inc.
|
25.25% | 0.349 | 20.32% | 0.89x |
|
KIDS
OrthoPediatrics Corp.
|
22.39% | -0.034 | 21.68% | 3.39x |
|
LUCY
Innovative Eyewear, Inc.
|
1.01% | 5.608 | 1.04% | 9.17x |
|
STAA
STAAR Surgical Co.
|
9.96% | 0.980 | 2.95% | 4.10x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NXGL
NexGel, Inc.
|
$1.2M | -$725K | -33.25% | -51.15% | -24.71% | -$793K |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
COO
The Cooper Cos., Inc.
|
$601M | $140.4M | 3.45% | 4.56% | 13.18% | $149.9M |
|
KIDS
OrthoPediatrics Corp.
|
$40M | -$4.9M | -10.3% | -12.83% | -7.95% | -$3.4M |
|
LUCY
Innovative Eyewear, Inc.
|
$244.8K | -$1.9M | -79.57% | -80% | -287.5% | -$1.5M |
|
STAA
STAAR Surgical Co.
|
$76.6M | $44.5M | -23.38% | -25.83% | 46.96% | $1.8M |
NexGel, Inc. vs. Competitors
-
Which has Higher Returns NXGL or CATX?
Perspective Therapeutics, Inc. has a net margin of -22.05% compared to NexGel, Inc.'s net margin of -12425.36%. NexGel, Inc.'s return on equity of -51.15% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital NXGLNexGel, Inc.40.93% -$0.08 $8.8M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About NXGL or CATX?
NexGel, Inc. has a consensus price target of $6.00, signalling upside risk potential of 277.36%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 349.19%. Given that Perspective Therapeutics, Inc. has higher upside potential than NexGel, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than NexGel, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NXGLNexGel, Inc.0 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is NXGL or CATX More Risky?
NexGel, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock NXGL or CATX?
NexGel, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NexGel, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXGL or CATX?
NexGel, Inc. quarterly revenues are $2.9M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. NexGel, Inc.'s net income of -$647K is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, NexGel, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NexGel, Inc. is 1.04x versus 190.87x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXGLNexGel, Inc.1.04x -- $2.9M -$647K CATXPerspective Therapeutics, Inc.190.87x -- $209K -$26M
-
Which has Higher Returns NXGL or COO?
The Cooper Cos., Inc. has a net margin of -22.05% compared to NexGel, Inc.'s net margin of 7.94%. NexGel, Inc.'s return on equity of -51.15% beat The Cooper Cos., Inc.'s return on equity of 4.56%.
Company Gross Margin Earnings Per Share Invested Capital NXGLNexGel, Inc.40.93% -$0.08 $8.8M COOThe Cooper Cos., Inc.56.42% $0.43 $11B -
What do Analysts Say About NXGL or COO?
NexGel, Inc. has a consensus price target of $6.00, signalling upside risk potential of 277.36%. On the other hand The Cooper Cos., Inc. has an analysts' consensus of $90.50 which suggests that it could grow by 9.6%. Given that NexGel, Inc. has higher upside potential than The Cooper Cos., Inc., analysts believe NexGel, Inc. is more attractive than The Cooper Cos., Inc..
Company Buy Ratings Hold Ratings Sell Ratings NXGLNexGel, Inc.0 0 0 COOThe Cooper Cos., Inc.6 7 1 -
Is NXGL or COO More Risky?
NexGel, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison The Cooper Cos., Inc. has a beta of 1.048, suggesting its more volatile than the S&P 500 by 4.779%.
-
Which is a Better Dividend Stock NXGL or COO?
NexGel, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cooper Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. NexGel, Inc. pays -- of its earnings as a dividend. The Cooper Cos., Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXGL or COO?
NexGel, Inc. quarterly revenues are $2.9M, which are smaller than The Cooper Cos., Inc. quarterly revenues of $1.1B. NexGel, Inc.'s net income of -$647K is lower than The Cooper Cos., Inc.'s net income of $84.6M. Notably, NexGel, Inc.'s price-to-earnings ratio is -- while The Cooper Cos., Inc.'s PE ratio is 44.06x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NexGel, Inc. is 1.04x versus 4.04x for The Cooper Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXGLNexGel, Inc.1.04x -- $2.9M -$647K COOThe Cooper Cos., Inc.4.04x 44.06x $1.1B $84.6M
-
Which has Higher Returns NXGL or KIDS?
OrthoPediatrics Corp. has a net margin of -22.05% compared to NexGel, Inc.'s net margin of -19.22%. NexGel, Inc.'s return on equity of -51.15% beat OrthoPediatrics Corp.'s return on equity of -12.83%.
Company Gross Margin Earnings Per Share Invested Capital NXGLNexGel, Inc.40.93% -$0.08 $8.8M KIDSOrthoPediatrics Corp.65.27% -$0.50 $450.1M -
What do Analysts Say About NXGL or KIDS?
NexGel, Inc. has a consensus price target of $6.00, signalling upside risk potential of 277.36%. On the other hand OrthoPediatrics Corp. has an analysts' consensus of $24.13 which suggests that it could grow by 38.57%. Given that NexGel, Inc. has higher upside potential than OrthoPediatrics Corp., analysts believe NexGel, Inc. is more attractive than OrthoPediatrics Corp..
Company Buy Ratings Hold Ratings Sell Ratings NXGLNexGel, Inc.0 0 0 KIDSOrthoPediatrics Corp.4 1 0 -
Is NXGL or KIDS More Risky?
NexGel, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison OrthoPediatrics Corp. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.186%.
-
Which is a Better Dividend Stock NXGL or KIDS?
NexGel, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OrthoPediatrics Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NexGel, Inc. pays -- of its earnings as a dividend. OrthoPediatrics Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXGL or KIDS?
NexGel, Inc. quarterly revenues are $2.9M, which are smaller than OrthoPediatrics Corp. quarterly revenues of $61.3M. NexGel, Inc.'s net income of -$647K is higher than OrthoPediatrics Corp.'s net income of -$11.8M. Notably, NexGel, Inc.'s price-to-earnings ratio is -- while OrthoPediatrics Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NexGel, Inc. is 1.04x versus 1.79x for OrthoPediatrics Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXGLNexGel, Inc.1.04x -- $2.9M -$647K KIDSOrthoPediatrics Corp.1.79x -- $61.3M -$11.8M
-
Which has Higher Returns NXGL or LUCY?
Innovative Eyewear, Inc. has a net margin of -22.05% compared to NexGel, Inc.'s net margin of -274.85%. NexGel, Inc.'s return on equity of -51.15% beat Innovative Eyewear, Inc.'s return on equity of -80%.
Company Gross Margin Earnings Per Share Invested Capital NXGLNexGel, Inc.40.93% -$0.08 $8.8M LUCYInnovative Eyewear, Inc.36.64% -$0.38 $10.4M -
What do Analysts Say About NXGL or LUCY?
NexGel, Inc. has a consensus price target of $6.00, signalling upside risk potential of 277.36%. On the other hand Innovative Eyewear, Inc. has an analysts' consensus of $3.00 which suggests that it could grow by 120.59%. Given that NexGel, Inc. has higher upside potential than Innovative Eyewear, Inc., analysts believe NexGel, Inc. is more attractive than Innovative Eyewear, Inc..
Company Buy Ratings Hold Ratings Sell Ratings NXGLNexGel, Inc.0 0 0 LUCYInnovative Eyewear, Inc.0 0 0 -
Is NXGL or LUCY More Risky?
NexGel, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Innovative Eyewear, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock NXGL or LUCY?
NexGel, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Innovative Eyewear, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NexGel, Inc. pays -- of its earnings as a dividend. Innovative Eyewear, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXGL or LUCY?
NexGel, Inc. quarterly revenues are $2.9M, which are larger than Innovative Eyewear, Inc. quarterly revenues of $668.1K. NexGel, Inc.'s net income of -$647K is higher than Innovative Eyewear, Inc.'s net income of -$1.8M. Notably, NexGel, Inc.'s price-to-earnings ratio is -- while Innovative Eyewear, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NexGel, Inc. is 1.04x versus 1.85x for Innovative Eyewear, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXGLNexGel, Inc.1.04x -- $2.9M -$647K LUCYInnovative Eyewear, Inc.1.85x -- $668.1K -$1.8M
-
Which has Higher Returns NXGL or STAA?
STAAR Surgical Co. has a net margin of -22.05% compared to NexGel, Inc.'s net margin of 9.38%. NexGel, Inc.'s return on equity of -51.15% beat STAAR Surgical Co.'s return on equity of -25.83%.
Company Gross Margin Earnings Per Share Invested Capital NXGLNexGel, Inc.40.93% -$0.08 $8.8M STAASTAAR Surgical Co.80.89% $0.18 $392.9M -
What do Analysts Say About NXGL or STAA?
NexGel, Inc. has a consensus price target of $6.00, signalling upside risk potential of 277.36%. On the other hand STAAR Surgical Co. has an analysts' consensus of $26.56 which suggests that it could grow by 12.41%. Given that NexGel, Inc. has higher upside potential than STAAR Surgical Co., analysts believe NexGel, Inc. is more attractive than STAAR Surgical Co..
Company Buy Ratings Hold Ratings Sell Ratings NXGLNexGel, Inc.0 0 0 STAASTAAR Surgical Co.1 9 0 -
Is NXGL or STAA More Risky?
NexGel, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison STAAR Surgical Co. has a beta of 1.008, suggesting its more volatile than the S&P 500 by 0.806%.
-
Which is a Better Dividend Stock NXGL or STAA?
NexGel, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. STAAR Surgical Co. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. NexGel, Inc. pays -- of its earnings as a dividend. STAAR Surgical Co. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios NXGL or STAA?
NexGel, Inc. quarterly revenues are $2.9M, which are smaller than STAAR Surgical Co. quarterly revenues of $94.7M. NexGel, Inc.'s net income of -$647K is lower than STAAR Surgical Co.'s net income of $8.9M. Notably, NexGel, Inc.'s price-to-earnings ratio is -- while STAAR Surgical Co.'s PE ratio is 49.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for NexGel, Inc. is 1.04x versus 5.09x for STAAR Surgical Co.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income NXGLNexGel, Inc.1.04x -- $2.9M -$647K STAASTAAR Surgical Co.5.09x 49.73x $94.7M $8.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
